TNYA CIK: 1858848

Tenaya Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
255
FY22:
194
FY23:
112
FY24:
67.4
FY25:
106
(positive)
Change from FY21 to FY25
millions USD
FY21:
58.8
FY22:
85.2
FY23:
58.9
FY24:
52.6
FY25:
41.3
Total assets
Change from FY21 to FY25
millions USD
FY21:
314
FY22:
279
FY23:
171
FY24:
120
FY25:
147

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
21.8
FY22:
24.2
FY23:
22.7
FY24:
16.0
FY25:
15.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
13.9
FY22:
11.3
FY23:
8.36
FY24:
11.1
FY25:
8.22
(positive)
Change from FY21 to FY25
millions USD
FY21:
279
FY22:
243
FY23:
139
FY24:
92.9
FY25:
123
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
314
FY22:
279
FY23:
171
FY24:
120
FY25:
147

All amounts in millions USD Data source:SEC EDGAR